KR20250009492A - Tyk2 억제제의 결정질 형태 및 그의 용도 - Google Patents

Tyk2 억제제의 결정질 형태 및 그의 용도 Download PDF

Info

Publication number
KR20250009492A
KR20250009492A KR1020247041063A KR20247041063A KR20250009492A KR 20250009492 A KR20250009492 A KR 20250009492A KR 1020247041063 A KR1020247041063 A KR 1020247041063A KR 20247041063 A KR20247041063 A KR 20247041063A KR 20250009492 A KR20250009492 A KR 20250009492A
Authority
KR
South Korea
Prior art keywords
crystalline form
powder
ray diffraction
diffraction pattern
degrees
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247041063A
Other languages
English (en)
Korean (ko)
Inventor
콜봇 바이
트래비스 레마척
Original Assignee
알루미스 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 알루미스 인크. filed Critical 알루미스 인크.
Publication of KR20250009492A publication Critical patent/KR20250009492A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020247041063A 2022-05-13 2023-05-12 Tyk2 억제제의 결정질 형태 및 그의 용도 Pending KR20250009492A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263341528P 2022-05-13 2022-05-13
US63/341,528 2022-05-13
US202263405577P 2022-09-12 2022-09-12
US63/405,577 2022-09-12
PCT/US2023/021986 WO2023220338A1 (en) 2022-05-13 2023-05-12 Crystalline forms of a tyk2 inhibitor and uses thereof

Publications (1)

Publication Number Publication Date
KR20250009492A true KR20250009492A (ko) 2025-01-17

Family

ID=86760338

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247041063A Pending KR20250009492A (ko) 2022-05-13 2023-05-12 Tyk2 억제제의 결정질 형태 및 그의 용도

Country Status (12)

Country Link
US (1) US20260209205A1 (cg-RX-API-DMAC7.html)
EP (1) EP4522602A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025516683A (cg-RX-API-DMAC7.html)
KR (1) KR20250009492A (cg-RX-API-DMAC7.html)
CN (1) CN119907791A (cg-RX-API-DMAC7.html)
AU (1) AU2023269081A1 (cg-RX-API-DMAC7.html)
CA (1) CA3253365A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024003456A1 (cg-RX-API-DMAC7.html)
IL (1) IL317011A (cg-RX-API-DMAC7.html)
MX (1) MX2024014000A (cg-RX-API-DMAC7.html)
TW (1) TW202409007A (cg-RX-API-DMAC7.html)
WO (1) WO2023220338A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202428571A (zh) * 2022-10-10 2024-07-16 美商雅盧米斯公司 Tyk2抑制劑之晶型及其用途
WO2026019902A1 (en) * 2024-07-16 2026-01-22 Alumis Inc. Crystalline forms of a tyk2 inhibitor and uses thereof
WO2026128621A2 (en) * 2024-12-12 2026-06-18 Alumis Inc. Process of making tyk2 inhibitors and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS66346B1 (sr) * 2018-10-22 2025-01-31 Alumis Inc Inhibitori tyk2 i njihova upotreba

Also Published As

Publication number Publication date
WO2023220338A1 (en) 2023-11-16
EP4522602A1 (en) 2025-03-19
IL317011A (en) 2025-01-01
TW202409007A (zh) 2024-03-01
MX2024014000A (es) 2025-02-10
US20260209205A1 (en) 2026-07-23
AU2023269081A1 (en) 2024-11-28
JP2025516683A (ja) 2025-05-30
CL2024003456A1 (es) 2025-04-25
CN119907791A (zh) 2025-04-29
CA3253365A1 (en) 2023-11-16

Similar Documents

Publication Publication Date Title
JP6846574B2 (ja) スルホンアミド化合物およびその使用
TW202409007A (zh) Tyk2抑制劑之晶型及其用途
US20250376459A1 (en) Crystalline forms of a tyk2 inhibitor and uses thereof
WO2016151304A1 (en) Novel polymorphic form x of nilotinib dihydrochloride hydrate
US20240182443A1 (en) Polymorphic forms of compound and preparation method therefor and application thereof
US20260138965A1 (en) Crystalline forms of a tyk2 inhibitor and uses thereof
US20240368185A1 (en) Macrocyclic azolopyridines
WO2026019902A1 (en) Crystalline forms of a tyk2 inhibitor and uses thereof
WO2026019908A1 (en) Crystalline forms of a tyk2 inhibitor and uses thereof
TW202610624A (zh) Tyk2抑制劑之晶型及其用途
TW202334088A (zh) 固體形式
CN110903291B (zh) 一种杂芳基并[4,3-c]嘧啶-5-胺类衍生物的盐、盐的晶型及制备方法
CN115772123A (zh) 固体形式
HK40023760B (en) Sulfonamide compounds and use thereof

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000